key: cord-0764006-63troru3 authors: Wang, Edina; Tsai, C. Jillian; Miller, Robert C. title: The international response to the COVID-19 pandemic in radiation oncology date: 2020-06-29 journal: Adv Radiat Oncol DOI: 10.1016/j.adro.2020.06.015 sha: bc221452d6cb8bc75814364afba3d7db7b0e2439 doc_id: 764006 cord_uid: 63troru3 nan In March of 2020, as it became apparent that the COVID-19 pandemic would impact radiation oncology clinic operations globally, health care professionals in the United States and elsewhere began to search for information to help prepare their clinics for safe operations. In response, the international radiation oncology responded to share experiences and best practices with unprecedented speed. Figure #1 shows the increase in manuscript volume published in ASTRO's Advances in Radiation Oncology during this time versus the prior year. The articles included in this special issue were part of this response and cover a diversity of topics pertinent to the practice of radiation oncology around the world. . Initially, the submitted manuscripts focused on topics ranging from enhancing patient and staff safety to determining optimal cancer treatment strategies. Over time, the focus shifted to the detection of COVID-19 with the imaging performed in radiation oncology as well as to potential radiation-related risk factors in COVID-19 morbidity. Overall, these articles have offered perspectives and guidance on novel challenges in the practice of radiation oncology and their topics continue to evolve at the time this manuscript goes to press. They will also serve as a permanent written history of the challenges faced by our profession as the pandemic evolved. Initially, radiation oncologists in global COVID-19 hot spots began describing the procedures and policies they were implementing to help protect their patients and staff in response to the spread of the virus. Early manuscripts from European and Asian institutions described their experiences creating a patient triage workflow, facility decontamination protocols, and the critical importance of personal protective equipment. They have also described the measures employed to limit the impact of the virus on clinic operations. These measures and policies provided guidance for other radiation oncology clinics as they dealt with this pandemic. The example provided by Krengli et al has received 24 citations in PubMed less than three months after publication. (1) With changes in clinic operations and with the recognition of resource constraints, attention was then turned to determining the optimal management of cancer during the pandemic. Early published reports suggested that patients with cancer can be at an increased risk of infection and complications from COVID-19 than non-cancer patients. (2) Consequently, the international radiation oncology community considered methods to balance the benefits of cancer treatment with the risks of COVID-19 exposure and infection. Public interest soon was subsequently focused on evidence based approaches to altering treatment fractionation and ways to safely delay therapy in order to reduce patient density in radiation oncology clinics. For example, Braunstein and colleagues discussed approaches to defer or shorten breast cancer radiation therapy. (3) Wu and colleagues discussed their considerations for thoracic radiation therapy including adopting maximal evidence-based hypofractionation. (4) Romesser and colleagues discuss a paradigm change at their institution from total neoadjuvant therapy with a preference for long course chemoradiation to short course radiation therapy for locally advanced rectal cancer. (5) As the situation around the world continued to evolve, joint papers from the American Society of Radiation Oncology and the European Society for Radiotherapy and Oncology and other ad hoc multi-institutional groups provided recommendations for common disease sites in Advances, the Red Journal, and Radiotherapy and Oncology. Included in this issue, Zaorsky and colleagues describe recommendations to avoid, reduce, or delay radiation therapy treatment for different clinical scenarios in prostate cancer. (6) As the situation with COVID-19 evolves, we will likely continue to see ongoing evaluations and changes in recommendations for various cancer treatment strategies. There has also been recent interest in detecting radiographic signs of SARS-CoV-2 infection on imaging that is performed as a part of radiation therapy planning and delivery including cone beam CT and CT simulation. In this special Advances edition are multiple case reports and case series that describe how clinicians can detect radiographic changes that may help screen and identify COVID-19, potential confounders on imaging, as well as subsequent management considerations following suspicion of SARS-CoV-2 infection. (7) Finally, there have been studies in regard to radiation therapy related risk factors to consider in a patient with positive COVID-19. A manuscript by Grellier and colleagues discusses the association of regional lymph node irradiation and lung damage in COVID-19 positive patients. (8) Kabarriti and colleagues also consider the association of prior lung radiation extent and mortality in patients with COVID-19 and cancer history in a New York practice. (9) Running a Radiation Oncology Department at the time of coronavirus: an Italian experience Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Breast radiotherapy under COVID-19 pandemic resource constraints --approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States Thoracic radiation therapy during COVID-19: provisional guidelines from a comprehensive cancer center within a pandemic epicenter Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center Prostate Cancer Radiotherapy Recommendations in Response to COVID-19 Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic Regional Lymph Node Irradiation in Breast Cancer May Worsen Lung Damage in Coronavirus Disease 2019 Positive Patients Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history We express our gratitude to the international community of contributors who have shared their experiences and perspectives.